Article
Current Status of Familial LCAT Deficiency in Japan.
Journal of atherosclerosis and thrombosis - 1 Jul 2021
Kuroda Masayuki, Bujo Hideaki, Yokote Koutaro, Murano Takeyoshi, Yamaguchi Takashi, Ogura Masatsune, Ikewaki Katsunori, Koseki Masahiro, Takeuchi Yasuo, Nakatsuka Atsuko, Hori Mika, Matsuki Kota, Miida Takashi, Yokoyama Shinji, Wada Jun, Harada-Shiba Mariko
Abstract excerpt
Lecithin cholesterol acyltransferase (LCAT) is a lipid-modification enzyme that catalyzes the transfer of the acyl chain from the second position of lecithin to the hydroxyl group of cholesterol (FC) on plasma lipoproteins to form cholesteryl acylester and lysolecithin. Familial LCAT deficiency is an intractable autosomal recessive disorder caused by inherited dysfunction of the LCAT enzyme. The disease appears...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
